ADO09 formulation
Sponsors
Adocia
Conditions
Type 1 Diabetes Mellitus
Phase 1
A Trial to Assess a Co-formulation of an Insulin Analog and Pramlintide in Subjects With Type 1 Diabetes Mellitus
CompletedNCT03916640
Start: 2019-01-04End: 2019-03-01Updated: 2019-04-16
A Trial to Assess Safety and Efficacy of ADO09 Versus Insulin Aspart in Subjects With Type 1 Diabetes Mellitus
CompletedNCT03981627
Start: 2019-06-06End: 2020-06-27Updated: 2020-11-30